WP
RCUS icon

Woodline Partners’s Arcus Biosciences RCUS Stock Holding History

Woodline Partners’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.7M Sell
3,007,798
-770,000
-20% -$19M 0.29% 78
2026
Q1 		$81.6M Buy
3,777,798
+8,010
+0.2% +$173K 0.31% 61
2025
Q4 		$89.8M Buy
3,769,788
+104
+0% +$2.12K 0.35% 57
2025
Q3 		$51.3M Sell
3,769,684
-230,345
-6% -$2.4M 0.24% 108
2025
Q2 		$32.6M Sell
4,000,029
-1,127,275
-22% -$9.63M 0.17% 168
2025
Q1 		$40.2M Buy
5,127,304
+1,603,367
+45% +$18.6M 0.26% 116
2024
Q4 		$52.5M Buy
3,523,937
+45,497
+1% +$743K 0.35% 72
2024
Q3 		$53.2M Sell
3,478,440
-766,781
-18% -$12.1M 0.45% 57
2024
Q2 		$64.7M Buy
4,245,221
+1,361,564
+47% +$22M 0.62% 37
2024
Q1 		$54.4M Buy
2,883,657
+1,846,375
+178% +$31.9M 0.5% 52
2023
Q4 		$19.8M Hold
1,037,282
– – 0.22% 143
2023
Q3 		$18.6M Buy
1,037,282
+789,282
+318% +$15.9M 0.22% 141
2023
Q2 		$5.04M Buy
+248,000
New +$4.72M 0.06% 289
2023
Q1 		– Sell
-1,201,150
Closed -$24.8M – 758
2022
Q4 		$24.8M Buy
+1,201,150
New +$33.1M 0.33% 80
2022
Q2 		– Sell
-261,419
Closed -$8.25M – 872
2022
Q1 		$8.25M Sell
261,419
-1,445,006
-85% -$48.4M 0.13% 190
2021
Q4 		$69.1M Buy
1,706,425
+7,312
+0.4% +$284K 0.99% 15
2021
Q3 		$59.2M Buy
1,699,113
+35,545
+2% +$1.11M 0.97% 20
2021
Q2 		$45.7M Buy
1,663,568
+425,838
+34% +$12.2M 0.85% 23
2021
Q1 		$34.8M Buy
+1,237,730
New +$43.1M 0.77% 34
2020
Q2 		– Sell
-98,516
Closed -$1.37M – 180
2020
Q1 		$1.37M Buy
+98,516
New +$1.23M 0.1% 122

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodline Partners's RCUS Position: Q2 2026 in Review

Woodline Partners reduced its Arcus Biosciences (RCUS) stake by 20% in Q2 2026, selling an estimated $19M and leaving 3,007,798 shares worth $92.7M. The position accounts for 0.29% of the portfolio, ranked #78.

Woodline Partners first reported a position in RCUS in Q1 2020 and has held it in 20 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Woodline Partners held 3,007,798 shares of Arcus Biosciences worth $92.7M as of Q2 2026.
  • Woodline Partners sold 770,000 Arcus Biosciences shares in Q2 2026, an estimated $19M.
  • Arcus Biosciences made up 0.29% of Woodline Partners's portfolio in Q2 2026, its #78 holding.
  • Woodline Partners first reported a position in Arcus Biosciences in Q1 2020 and has held it in 20 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.